NYSE$EHC
Encompass Health Corp · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
Encompass Health's Q1 2024 performance was strong, driven by revenue and discharge growth, along with effective expense management, leading to increased profitability and positive outlook.
Encompass Health reported a strong first quarter with a 13.4% increase in revenue, driven by a 10.0% increase in discharges. Adjusted EBITDA grew by 19.2%, and the company increased its full-year guidance.
- Revenue growth of 13.4% resulted primarily from discharge growth of 10.0%, including same-store growth of 6.7%. Net revenue per discharge grew 2.8%.
- Cash flows provided by operating activities increased 4.8% to $238.8 million, primarily due to an increase in net income partly offset by changes in working capital.
- Adjusted EBITDA increased 19.2%, primarily from increased revenue and overall expense management.
- The Company increased its full-year guidance.
Headline financials
Revenue & EPS history
Encompass Health · Revenue · Quarterly
$1.32B
Forward guidance
The Company increased its full-year guidance as follows: Net operating revenue $5,250 to $5,325 million, Adjusted EBITDA $1,030 to $1,065 million, Adjusted earnings per share from continuing operations attributable to Encompass Health $3.86 to $4.11
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
+1.2%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+2.5%
Avg return
30 days after
64%
42 / 66 earnings
Positive
+11.8%
Q1 2025
Best reaction
-9.0%
Q1 2015
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.1% | +5.0% | +6.0% | |
| Q4 2025 | +5.9% | +13.9% | +7.4% | |
| Q3 2025 | -6.9% | -6.8% | -7.5% | |
| Q1 2025 | +11.8% | +15.4% | +17.2% | |
| Q4 2024 | +1.3% | -0.6% | +0.7% | |
| Q3 2024 | +7.0% | +5.8% | +10.0% | |
| Q2 2024 | -8.7% | -7.5% | +1.0% | |
| Q1 2024 | +0.3% | +1.4% | +2.5% | |
| Q4 2023 | +1.7% | +1.9% | +5.9% | |
| Q3 2023 | -1.9% | +0.9% | +6.7% | |
| Q2 2023 | +5.0% | +6.4% | +7.6% | |
| Q1 2023 | +0.7% | -0.6% | -5.9% | |
| Q4 2022 | +1.6% | +3.1% | -9.1% | |
| Q3 2022 | +6.4% | +11.1% | +16.6% | |
| Q2 2022 | +0.6% | +4.5% | -4.0% | |
| Q1 2022 | +2.6% | +2.5% | -2.0% | |
| Q4 2021 | +1.5% | -2.9% | +8.8% | |
| Q3 2021 | -6.0% | -5.8% | -9.8% | |
| Q2 2021 | +0.7% | +3.5% | -4.1% | |
| Q1 2021 | -1.6% | -2.7% | -2.5% | |
| Q4 2020 | -3.9% | -6.2% | -6.1% | |
| Q3 2020 | -2.6% | -3.0% | +25.9% | |
| Q2 2020 | +4.5% | +3.1% | -6.4% | |
| Q1 2020 | -1.1% | -7.1% | +6.4% | |
| Q4 2019 | +0.4% | +3.1% | -2.6% | |
| Q3 2019 | -5.8% | +2.0% | +5.5% | |
| Q2 2019 | -4.0% | -7.4% | -12.6% | |
| Q1 2019 | +5.3% | +3.6% | -4.6% | |
| Q4 2018 | -4.4% | -3.5% | -13.3% | |
| Q3 2018 | -5.7% | -4.0% | +1.4% | |
| Q2 2018 | +8.8% | +5.9% | +17.4% | |
| Q1 2018 | +7.2% | +7.3% | +10.3% | |
| Q4 2017 | +3.0% | +3.9% | +7.7% | |
| Q3 2017 | +1.8% | +2.0% | +8.7% | |
| Q2 2017 | +1.9% | -0.2% | +3.6% | |
| Q1 2017 | +7.9% | +10.0% | +6.3% | |
| Q4 2016 | +0.1% | +0.5% | -1.9% | |
| Q3 2016 | +1.8% | +0.7% | +5.6% | |
| Q2 2016 | +6.7% | +3.1% | -0.3% | |
| Q1 2016 | +10.9% | — | — | |
| Q4 2015 | +9.2% | — | — | |
| Q3 2015 | -0.3% | — | — | |
| Q2 2015 | -2.9% | — | — | |
| Q1 2015 | -9.0% | — | — | |
| Q4 2014 | -4.7% | — | — | |
| Q3 2014 | -3.0% | — | — | |
| Q2 2014 | +7.4% | — | — | |
| Q1 2014 | -0.4% | — | — | |
| Q4 2013 | -2.8% | — | — | |
| Q3 2013 | +0.6% | — | — | |
| Q2 2013 | +4.7% | — | — | |
| Q1 2013 | +3.1% | — | — | |
| Q4 2012 | +7.2% | — | — | |
| Q3 2012 | +2.5% | — | — | |
| Q2 2012 | -3.7% | — | — | |
| Q1 2012 | +9.2% | — | — | |
| Q4 2010 | +3.9% | — | — | |
| Q4 2011 | +3.9% | — | — | |
| Q3 2011 | -1.0% | — | — | |
| Q2 2011 | -9.0% | — | — | |
| Q1 2010 | +0.4% | — | — | |
| Q1 2011 | +2.5% | — | — | |
| Q4 2008 | +7.8% | — | — | |
| Q3 2010 | +2.2% | — | — | |
| Q2 2010 | -1.0% | — | — | |
| Q4 2009 | -1.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro